chr19-5893092-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001193375.3(NDUFA11):c.512G>A(p.Gly171Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000195 in 1,535,986 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001193375.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NDUFA11 | NM_001193375.3 | c.512G>A | p.Gly171Glu | missense_variant | 4/4 | NP_001180304.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ENSG00000267740 | ENST00000586349.5 | c.382+3361G>A | intron_variant | 2 | ENSP00000466639.1 | |||||
NDUFA11 | ENST00000418389.6 | c.512G>A | p.Gly171Glu | missense_variant | 4/4 | 2 | ENSP00000389160.1 | |||
ENSG00000267740 | ENST00000585661.1 | c.307+3361G>A | intron_variant | 2 | ENSP00000467210.1 | |||||
ENSG00000267740 | ENST00000592091.5 | n.313+3361G>A | intron_variant | 2 | ENSP00000465499.1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152142Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000292 AC: 4AN: 136756Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 74338
GnomAD4 exome AF: 0.0000101 AC: 14AN: 1383844Hom.: 0 Cov.: 33 AF XY: 0.00000146 AC XY: 1AN XY: 682866
GnomAD4 genome AF: 0.000105 AC: 16AN: 152142Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74324
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 04, 2021 | The c.512G>A (p.G171E) alteration is located in exon 4 (coding exon 4) of the NDUFA11 gene. This alteration results from a G to A substitution at nucleotide position 512, causing the glycine (G) at amino acid position 171 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at